Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Other Non-Current Liabilities (2020 - 2023)

Journey Medical (DERM) has disclosed Other Non-Current Liabilities for 4 consecutive years, with $133000.0 as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Other Non-Current Liabilities fell 96.51% year-over-year to $133000.0, compared with a TTM value of $133000.0 through Jun 2023, down 96.51%, and an annual FY2022 reading of $1.4 million, down 61.07% over the prior year.
  • Other Non-Current Liabilities was $133000.0 for Q2 2023 at Journey Medical, down from $1.4 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $4.4 million in Q3 2021 and bottomed at $99000.0 in Q4 2020.
  • Average Other Non-Current Liabilities over 4 years is $2.2 million, with a median of $1.4 million recorded in 2023.
  • The sharpest move saw Other Non-Current Liabilities surged 3563.64% in 2021, then crashed 96.51% in 2023.
  • Year by year, Other Non-Current Liabilities stood at $99000.0 in 2020, then soared by 3563.64% to $3.6 million in 2021, then plummeted by 61.07% to $1.4 million in 2022, then tumbled by 90.58% to $133000.0 in 2023.
  • Business Quant data shows Other Non-Current Liabilities for DERM at $133000.0 in Q2 2023, $1.4 million in Q1 2023, and $1.4 million in Q4 2022.